Associated Papers
Identifying Genetic Factors Influencing the Development of Anti-Drug Antibodies in Inflammatory Bowel Disease: A Scoping Review.
Culmsee-Holm FB et al.
Journal of Inflammation Research, 2025
Pharmacogenetic variants of infliximab response in young patients with inflammatory bowel disease.
Curci D et al.
Clinical and Translational Science, 2021
Mucosal IgG in inflammatory bowel disease - a question of (sub)class?
Castro-Dopico T et al.
Gut Microbes, 2020
Analysis of Fcγ receptor IIIa and IIa polymorphisms: lack of correlation with outcome in trastuzumab-treated breast cancer patients.
Hurvitz SA et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research, 2012
Genetic profiling of GSTP1, DPYD, FCGR2A, FCGR3A and CCND1 genes in an Argentinian population.
Galván CA et al.
Clinical Biochemistry, 2011
Polymorphisms of CD16A and CD32 Fcγ receptors and circulating immune complexes in Ménière's disease: a case-control study.
Lopez-Escamez JA et al.
Bmc Medical Genetics, 2011
Functional variants of Fc gamma receptor (FCGR2A) and FCGR3A are not associated with susceptibility to systemic sclerosis in a large European Study (EUSTAR).
Alizadeh BZ et al.
The Journal of Rheumatology, 2010
Linkage and association study of FcgammaR polymorphisms in celiac disease.
Sareneva I et al.
Tissue Antigens, 2009
Select a paper to view details